Leading Indicators, Monday January 5, 2026 – Crystal Equity Research

Small-cap stocks in new downtrend according to average directional index, Mon Jan 5th - #INFU #LUCY #TOUR #ORKA #FLGT #DGNX #AVBP #TK #LB #CXM #CATO #AMPY - More: crystalequityresearch.com/leading-indi... - #smallcap

Ambulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026 InfuSystem Holdings, Inc., a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that the Centers for Medicare and Medicaid Services has added two of the electronic infusion pumps currently utilized by the Company within its Pain Management...

#INFU Ambulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026

www.stocktitan.net/news/INFU/ambulatory-inf...

InfuSystem Reports Third Quarter 2025 Financial Results InfuSystem (NYSE:INFU) reported third quarter 2025 results with net revenues of $36.5 million, up 3.3% year-over-year, and net income of $2.3 million (+25%).Adjusted EBITDA (non-GAAP) was $8.3 million, up 6% with a margin of 22.8%. Gross profit rose 9.3% to $20.8 million and gross margin improved to 57.1%. Year-to-date net operating cash flow was $17.3 million, up 38%.The Patient Services segment grew 7.6% to $22.4 million (wound care +115% driven by new PCD supplier), while Device Solutions declined 2.9% to $14.1 million. Company liquidity was $54.6 million. Management reaffirmed full-year 2025 guidance of net revenue growth 6–8% and Adjusted EBITDA margin ≥20%.

#INFU InfuSystem Reports Third Quarter 2025 Financial Results

www.stocktitan.net/news/INFU/infu-system-re...

InfuSystem Earnings Shatter Expectations: 262% Profit Jump Signals Major Turnaround Success Record Q2 revenue hits $36M with margins expanding 4.3%. Strong performance across Patient Services and Device Solutions drives exceptional growth. See full results.

#INFU InfuSystem Reports Second Quarter 2025 Financial Results

www.stocktitan.net/news/INFU/infu-system-re...

InfuSystem Reports First Quarter 2025 Financial Results InfuSystem Holdings (NYSE American: INFU) reported strong Q1 2025 financial results with record net revenues of $34.7 million, up 9% year-over-year. The company's Patient Services revenue increased 12% to $20.8 million, while Device Solutions revenue grew 4% to $13.9 million. Despite posting a net loss of $0.3 million ($0.01 per share), the company showed significant improvement from prior year's loss of $1.1 million. Adjusted EBITDA surged 64% to $6.3 million, with margin expanding to 18.2%. The company conducted stock repurchases totaling $3.0 million and maintained strong liquidity of $47.6 million. InfuSystem reaffirmed its 2025 guidance, projecting 8-10% revenue growth. The quarter also marked a leadership transition, with CEO Richard DiIorio stepping down and COO Carrie Lachance preparing to take the helm.

#INFU InfuSystem Reports First Quarter 2025 Financial Results

www.stocktitan.net/news/INFU/infu-system-re...

InfuSystem Taps 15-Year Veteran as CEO: Growth Accelerates with 10% Revenue Target Seasoned executive Carrie Lachance to lead InfuSystem's next growth phase. Company projects 10% revenue growth and margin expansion. Full strategic outlook inside.

#INFU InfuSystem Announces CEO Transition; Carrie Lachance to Become Chief Executive Officer

www.stocktitan.net/news/INFU/infu-system-an...

InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2024 InfuSystem Holdings (NYSE: INFU) reported strong financial results for Q4 and full year 2024, achieving record net revenues of $134.9 million, up 7% year-over-year. The company's performance showed significant improvements across key metrics:Patient Services revenue reached $80.4 million (+5%) while Device Solutions revenue hit $54.5 million (+11%). Notable achievements include:Record operating cash flow of $20.5 million (+82%)Adjusted EBITDA of $25.3 million (+13%)Net income of $2.3 million ($0.11 per diluted share)Gross margin improved to 52.2% (+2%)For 2025, InfuSystem projects revenue growth of 8-10% with Adjusted EBITDA margins expected to exceed 2024's 18.8%, despite planned technology upgrade investments of approximately $2.5 million.

#INFU InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2024

www.stocktitan.net/news/INFU/infu-system-an...

Charles River Associates to Present at Sidoti Small-Cap Conference in December | CRAI Stock News CRAI joins leading small-cap companies at Sidoti's December 4-5 virtual conference, scheduled to present on December 4th. Learn about investment opportunities in the small-cap market.

#CRAI #INFU #INTT Sidoti Events, LLC's Virtual December Small-Cap Conference

#StockMarket #stocks #investing

www.stocktitan.net/news/CRAI/sidoti-events-...

#INFU InfuSystem to Present at Sidoti Small Cap Conference on December 4, 2024

www.stocktitan.net/news/INFU/infu-system-to...

#INFU InfuSystem Appoints Ronald Hundzinski to the Board of Directors

www.stocktitan.net/news/INFU/infu-system-ap...

NEWS: ( NYSE: #INFU ) (INFU) Trading Signals

#StockMarket #News

Cry Fanart fot Infugames Character: Cry Youtuber: InfuGatito App: MedibangPaint #animegirl #horns #infugames #infu #infugatito

Cry Fanart fot Infugames
Character: Cry
Youtuber: InfuGatito
App: MedibangPaint
#animegirl #horns #infugames #infu #infugatito